About US
Contact us
-
Sutro Biopharma has landed another marquee name for its list of development partners for antibody-drug conjugates.Sutro Biopharma has landed another marquee name for its list of development partners for antibody-drug conjugates. Merck KGaA, which has been struggling in the clinic for years, has signed on with the2014/9/17
-
ROQUETTE China Launches Chinese Website(September16, 2014, Shanghai, China) ROQUETTE China is inviting visitors to explore its Chinese website. The new website was developed to provide the ultimate user-friendly experience with improved na2014/9/16
-
Meet Baxalta, the pharma spinoff Baxter plans to unleash in 2015When Abbott Laboratories ($ABT) told the world that its spun-off pharma business would bear the AbbVie ($ABBV) moniker, there were the usual marketing-speak explanations. Includes the name of its form2014/9/12
-
Pre-chemo nod for Medivation's Xtandi sets up showdown with J&J's ZytigaJohnson & Johnson's ($JNJ) next-gen prostate cancer pill,Zytiga, has been cruising since it hit the market back in April 2011, but now, it may be vulnerable to market share losses for the first ti2014/9/12
-
GSK partners with UK and South African research councils for NCDs in AfricaBritish drug-maker GlaxoSmithKline (GSK) has partnered with UK and South African medical research councils (MRC) to carry out research on non-communicable diseases (NCDs) in Africa. The £5m col2014/9/11
-
FDA grants approval for Keryx’s ferric citrate to treat dialysis patients with hyperphosphatemiaKeryx Biopharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its ferric citrate (formerly known as Zerenex), a new oral iron-based treatment for dialysis patients2014/9/11
-
The pressure's on Novo's marketing force as FDA nod for liraglutide nearsNovo Nordisk ($NVO) may be nearing the regulatory finish line with an obesity-fighting dose of liraglutide, up for debate by the FDA's advisers this week. But as its struggling rivals can attest, when2014/9/10
-
Judge: Merck must fight claims that it lied about mumps vaccine benefitsMerck ($MRK) tried to block two lawsuits claiming it lied about the efficacy of its mumps vaccine--but the pharma giant couldn't stop them. A federal judge in Pennsylvania refused to dismiss the lawsu2014/9/9
-
The top 10 best-selling multiple sclerosis drugs of 2013Want a surefire way to shake up a drug market? Introduce new medication options that make it easier for patients to manage their disease. MS drugmakers would know; their market is all of a sudden full2014/9/5
-
FDA clears sNDA for UCB’s Vimpat anti-epileptic drug as monotherapyThe US Food and Drug Administration (FDA) has cleared a supplemental new drug application (sNDA) for UCB's Vimpat (lacosamide) C-V as montherapy to treat partial-onset seizures in patients with epilep2014/9/4